Research and development activities
First written in FY2023-Q1. 6 of 8 entries say "Restated". Latest entry: FY2026-H1.
96 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「Research and development expenses for the current interim consolidated accounting period totaled ¥14.994 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」
Research and development expenses of ¥14.994 million were disclosed, while the company explained that there had been no material changes in its research and development activities. - FY2025-H1RestatedAnnual report
「Research and development expenses for the current interim consolidated accounting period totaled ¥12.029 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」
Research and development expenses of ¥12.029 million were disclosed, and the company explained that there had been no material changes in its research and development activities. - FY2024-Q3RestatedAnnual report
「Research and development expenses for the current third-quarter consolidated cumulative period totaled ¥26.119 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
Research and development expenses of ¥26.119 million were disclosed, and the company explained that there had been no material changes in its research and development activities. - FY2024-Q2RestatedAnnual report
「Research and development expenses for the current second-quarter consolidated cumulative period totaled ¥17.232 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
Research and development expenses of ¥17.232 million were disclosed, and the company explained that there had been no material changes in its research and development activities. - FY2023AdvancedAnnual report
「The total expenses incurred by the Group for research and development activities during the current consolidated fiscal year amounted to ¥32.097 million. The main research topics are as follows.」
In addition to the full-year amount of research and development expenses, 3 specific research and development projects covering woody biomass, marine biomass and organic farming have been disclosed. - FY2023-Q3RestatedAnnual report
「Research and development expenses for the current third-quarter consolidated cumulative period totaled ¥23.977 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The cumulative amount of research and development expenses was disclosed, while the company explained that there had been no material changes in its research and development activities. - FY2023-Q2RestatedAnnual report
「Research and development expenses for the current second-quarter consolidated cumulative period totaled ¥15.995 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
A new amount of research and development expenses was disclosed, while the company explained that there had been no material changes in its research and development activities. - FY2023-Q1First statedAnnual report
「Research and development expenses for the current first-quarter consolidated cumulative period totaled ¥7.992 million.」
The total amount of research and development expenses has been disclosed, while the company states that there have been no material changes in its research and development activities.